Showing 7981-7990 of 8647 results for "".
- UK Commits £210 Million Toward Global Efforts to Find COVID-19 Vaccinehttps://modernod.com/news/uk-commits-210-million-toward-global-efforts-to-find-covid-19-vaccine/2477469/The UK government said it would contribute £210 million ($255 million) toward international efforts aimed at finding a vaccine against the novel coronavirus, according to a FirstWord report. The funding will be channelled to the Coalition for Epidemic Preparedness Innovations (CEPI), which
- Live Webcast: COVID-19 Impact on Retina Practiceshttps://modernod.com/news/live-webcast-covid-19-impact-on-retina-practices/2477468/Bryn Mawr Communications (BMC) will host a live video webcast of its New Retina Radio podcast on Friday at 12 pm ET. The webcast, “How Retina Doctors Are Altering Their Treatments During the COVID-19 Crisis, and How They Can Anticipate What’s Next,” will be hosted by John W. Kitchens, MD. Panelis
- US ECPs’ Business Concerns and Stress Levels Grow, as Coronavirus Pandemic Impact Widenshttps://modernod.com/news/us-ecps-business-concerns-and-stress-levels-grow-as-coronavirus-pandemic-impact-widens/2477464/As the number of COVID-19 cases grow and more parts of the U.S. put “shelter-in-place” requests and mandates into place due to the coronavirus pandemic, the impact is growing more pronounced in the provider sector of business, according to a VisionMonday
- FDA Grants Gilead Request to Drop Orphan Drug Designation for Potential COVID-19 Treatment Remdesivirhttps://modernod.com/news/fda-grants-gilead-request-to-drop-orphan-drug-designation-for-potential-covid-19-treatment-remdesivir/2477465/The FDA on Wednesday withdrew an orphan drug designation it had granted Gilead Sciences a few days ago for its investigational antiviral remdesivir to treat COVID-19. The company, which had made the request, said it will waive all benefits that come with the designation, including an
- Bausch Health Donates Health Care Products And Supplies In Response To COVID-19 Pandemichttps://modernod.com/news/bausch-health-donates-health-care-products-and-supplies-in-response-to-covid-19-pandemic/2477458/Bausch Health Companies outlined several initiatives the company is taking to contribute to the fight against COVID-19. “Bausch Health is actively donating medicines and health care products to assist
- Results from First Clinical Study Using Danoprevir to Treat Naive and Experienced COVID-19 Patientshttps://modernod.com/news/results-from-first-clinical-study-using-danoprevir-to-treat-naive-and-experienced-covid-19-patients/2477455/Ascletis Pharma announced the first clinical study using Ganovo (danoprevir) to treat naive and experienced COVID-19 patients was published in medRxiv. The data from this small-sample clinical study showed that danoprevir combined with ritonavir is safe and well tolerated in all p
- Glaukos Provides COVID-19 Pandemic Updatehttps://modernod.com/news/glaukos-provides-covid-19-pandemic-update/2477449/Glaukos provided an update on the actions it is taking in response to the COVID-19 pandemic. In order to prioritize the health and safety of employees, healthcare professionals, patients and its communities, while continuing to support its customers, Glaukos implemented a number of measure
- ImprimisRx to Provide Healthcare Professionals With Telemedicine Serviceshttps://modernod.com/news/imprimisrx-to-provide-healthcare-professionals-with-telemedicine-services/2477446/ImprimisRx, a wholly-owned subsidiary of Harrow Health, announced that they have entered into an exclusive agreement with Doxy.me, a full-service telemedicine solution. The agreement will provide all ImprimisRx ophthalmology, optometry, and wellness practices with the Clinic level
- Working With BARDA and FDA on COVID-19 Countermeasureshttps://modernod.com/news/covid-19-working-with-barda-and-fda-on-covid-19-countermeasures/2477443/How can biotech and pharmaceutical companies work with the government in developing and supplying effective diagnostics, treatments and vaccines for COVID-19? What should these companies know? Join Arnold & Porter on Thursday, March 26 from 12–2 pm Eastern Time for an introduction to c
- The Vision Council Releases Midpoint March COVID-19 Optical Impact Consumer Study to Membershttps://modernod.com/news/the-vision-council-releases-midpoint-march-covid-19-optical-impact-consumer-study-to-members/2477445/The Vision Council has released the results of the Midpoint March COVID-19 Optical Impact Consumer Study to members. Conducted by The Vision Council’s research team as part of The Vision Council’s monthly VisionWatch survey, the Midpoint March survey builds upon the study launched in February to